Company Filing History:
Years Active: 2019
Title: Hye-Jung Han: Innovator in Cancer Research
Introduction
Hye-Jung Han is a prominent inventor based in Lafayette, CA (US). She has made significant contributions to the field of cancer research, particularly in understanding the role of long non-coding RNAs in aggressive cancer types. Her work is vital for developing new methods to evaluate and potentially treat cancer.
Latest Patents
Hye-Jung Han holds a patent for her invention titled "Long non-coding RNA expressed in aggressive cancer." This invention relates to a long non-coding RNA that is expressed in cancer. The patent provides methods and compositions for evaluating levels of this long non-coding RNA to assess the aggressiveness of cancer and for modulating its levels. She has 1 patent to her name.
Career Highlights
Hye-Jung Han is affiliated with the University of California, where she conducts her research. Her work has garnered attention for its potential impact on cancer diagnostics and treatment strategies.
Collaborations
Some of her notable coworkers include Terumi Kohwi-Shigematsu and Yoshinori Kohwi. Their collaborative efforts contribute to advancing research in the field of cancer biology.
Conclusion
Hye-Jung Han's innovative work in cancer research highlights the importance of long non-coding RNAs in understanding and treating aggressive cancers. Her contributions are paving the way for future advancements in cancer diagnostics and therapies.